Search research articles
Contact Us
Filters
Showing results (181-190 of 358) with videos related to
Page
of 36
Sort By:
Plos One
|
November 14, 2024
Prospective longitudinal study of men who have sex with men and transgender women to determine HIV incidence in two provinces in Thailand
Chawetsan Namwat, Warong Leela-Apiradee, Thawat Tiawilai, et al.
AIDS (London, England)
|
November 26, 2019
Activated PD-1+ CD4+ T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ART
Michael A Eller, Ting Hong, Matthew Creegan, et al.
Plos Pathogens
|
July 28, 2018
Evolution of HIV-1 within untreated individuals and at the population scale in Uganda
Jayna Raghwani, Andrew D Redd, Andrew F Longosz, et al.
Plos One
|
March 30, 2021
Clinical laboratory reference values in adults in Kisumu County, Western Kenya; hematology, chemistry and CD4
Valentine Sing'oei, Jew Ochola, John Owuoth, et al.
BMC Public Health
|
October 2, 2024
HIV incidence and its associated factors among young adults with multiple sexual partners in Maputo, Mozambique: a vaccine preparedness study
Ivalda Macicame, Nilesh Bhatt, Edna Viegas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 21, 2019
New Subtype B Containing HIV-1 Circulating Recombinant of sub-Saharan Africa Origin in Nigerian Men Who Have Sex With Men
Erik Billings, Gustavo H Kijak, Eric Sanders-Buell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 13, 2018
Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular Clones
Agnes-Laurence Chenine, Melanie Merbah, Lindsay Wieczorek, et al.
Plos One
|
February 10, 2015
Identification of immunodominant CD4-restricted epitopes co-located with antibody binding sites in individuals vaccinated with ALVAC-HIV and AIDSVAX B/E
Silvia Ratto-Kim, Mark S de Souza, Jeffrey R Currier, et al.
Plos One
|
November 19, 2010
Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate
Jeffrey R Currier, Viseth Ngauy, Mark S de Souza, et al.
The Lancet. Microbe
|
January 30, 2025
Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controlled trial
Meagan E Deming, Elizabeth R Brown, Monica A McArthur, et al.
Page
of 36
Search research articles
Search
Showing results (181-190 of 358) with videos related to
Sort By:
Page
of 36
Plos One
|
November 14, 2024
Prospective longitudinal study of men who have sex with men and transgender women to determine HIV incidence in two provinces in Thailand
Chawetsan Namwat, Warong Leela-Apiradee, Thawat Tiawilai, et al.
AIDS (London, England)
|
November 26, 2019
Activated PD-1+ CD4+ T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ART
Michael A Eller, Ting Hong, Matthew Creegan, et al.
Plos Pathogens
|
July 28, 2018
Evolution of HIV-1 within untreated individuals and at the population scale in Uganda
Jayna Raghwani, Andrew D Redd, Andrew F Longosz, et al.
Plos One
|
March 30, 2021
Clinical laboratory reference values in adults in Kisumu County, Western Kenya; hematology, chemistry and CD4
Valentine Sing'oei, Jew Ochola, John Owuoth, et al.
BMC Public Health
|
October 2, 2024
HIV incidence and its associated factors among young adults with multiple sexual partners in Maputo, Mozambique: a vaccine preparedness study
Ivalda Macicame, Nilesh Bhatt, Edna Viegas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 21, 2019
New Subtype B Containing HIV-1 Circulating Recombinant of sub-Saharan Africa Origin in Nigerian Men Who Have Sex With Men
Erik Billings, Gustavo H Kijak, Eric Sanders-Buell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 13, 2018
Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular Clones
Agnes-Laurence Chenine, Melanie Merbah, Lindsay Wieczorek, et al.
Plos One
|
February 10, 2015
Identification of immunodominant CD4-restricted epitopes co-located with antibody binding sites in individuals vaccinated with ALVAC-HIV and AIDSVAX B/E
Silvia Ratto-Kim, Mark S de Souza, Jeffrey R Currier, et al.
Plos One
|
November 19, 2010
Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate
Jeffrey R Currier, Viseth Ngauy, Mark S de Souza, et al.
The Lancet. Microbe
|
January 30, 2025
Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controlled trial
Meagan E Deming, Elizabeth R Brown, Monica A McArthur, et al.
Page
of 36